Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Shares Outstanding of 61.75 million shares for fiscal year 2023.
TREACE MEDICAL CONCEPTS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2023 | 61.75M | +11.0% |
| 2022 | 55.63M | +2.7% |
| 2021 | 54.18M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | 62.28M | +1.1% | +0.2% |
| June 30, 2024 | 62.18M | +1.1% | +0.4% |
| March 31, 2024 | 61.93M | +1.1% | +0.3% |
| December 31, 2023 | 61.75M | +11.0% | +0.2% |
| September 30, 2023 | 61.61M | +11.0% | +0.1% |
| June 30, 2023 | 61.53M | +11.1% | +0.4% |
| March 31, 2023 | 61.28M | +10.9% | +10.2% |
| December 31, 2022 | 55.63M | +2.7% | +0.2% |
- TREACE MEDICAL CONCEPTS, INC. showed an increase of +11.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2023 period, TREACE MEDICAL CONCEPTS, INC.’s shares outstanding has grown by 14.0% (from 54.18 million shares to 61.75 million shares).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on February 27, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: